Brief: Solara Active Pharma Sciences Says USFDA Concludes Inspection At Co's Visakhapatnam Facility With Zero Form 483 Inspectional Observations
30/01/2023 05:52
Jan 30 (Reuters) - Solara Active Pharma Sciences Ltd
SOLA.NS :
* USFDA CONCLUDES INSPECTION AT CO'S VISAKHAPATNAM FACILITY
WITH
ZERO FORM 483 INSPECTIONAL OBSERVATIONS
Source text for Eikon: ID:nNSE24DZNW
Further company coverage: SOLA.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Solara Active Pharma Sciences
See all newsIndia's Solara Active Pharma Sciences rises after quarterly profit
Brief: Solara Active Pharma Sciences Says Sept-Quarter Consol Net Profit 284.6 Million Rupees
Brief: Solara Active Pharma Sciences Says Tax Demand Of 1.62 Billion Rupees Reduced To Nil After Rectification
Brief: Solara Active Pharma Sciences June-Quarter Consol Net Profit 163.1 Million Rupees
Brief: Solara Active Pharma Sciences March-Quarter Consol Net Profit 96 Million Rupees